JNJ

Johnson & Johnson

Health Care

Pharmaceuticals

New Brunswick, New Jersey

Balance Sheet 32 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-29	2023-12-31	2023-01-01	2022-01-02	2021-01-03
Assets - CashAndCashEquivalents	$24.1B	$21.9B	$12.9B	$14.5B	$14.0B
Assets - MarketableSecuritiesCurrent	$417.0M	$1.1B	$9.4B	$17.1B	$11.2B
Assets - AccountsReceivable	$14.8B	$14.9B	$14.0B	$15.3B	$13.6B
Assets - Inventories	$12.4B	$11.2B	$10.3B	$10.4B	$9.3B
Assets - PrepaidExpensesAndOtherCurrentAssets	$4.1B	$4.5B	$2.9B	$3.7B	$3.1B
Assets - TotalCurrentAssets	$55.9B	$53.5B	$55.3B	$61.0B	$51.2B
Assets - Property,PlantAndEquipment	$20.5B	$19.9B	$18.0B	$19.0B	$18.8B
Assets - Goodwill	$44.2B	$36.6B	$36.0B	$25.4B	$36.4B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$37.6B	$34.2B	$38.5B	$46.4B	$53.4B
Assets - OperatingLeaseAssets	$1.1B	$1.0B	$1.1B	$900.0M	$1.0B
Assets - MarketableSecuritiesNoncurrent	$7.2B	$8.9B	$10.5B	$19.7B	$14.0B
Assets - DeferredTaxAssets	$15.2B	$12.7B	$12.8B	$12.6B	$12.5B
Assets - OtherNoncurrentAssets	$11.4B	$14.2B	$9.2B	$10.2B	$6.6B
Assets - TotalAssets	$180.1B	$167.6B	$187.4B	$182.0B	$174.9B
Liabilities - AccountsPayable	$10.3B	$9.6B	$9.9B	$11.1B	$9.5B
Liabilities - AccruedLiabilities	$7.9B	$7.0B	$5.3B	$4.7B	$4.9B
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$6.0B	$3.5B	$12.8B	$3.8B	$2.6B
Liabilities - TotalCurrentLiabilities	$50.3B	$46.3B	$55.8B	$45.2B	$42.5B
Liabilities - LongTermDebt	$30.7B	$25.9B	$26.9B	$30.0B	$32.6B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$1.2B	$1.1B	$1.3B	$1.0B	$1.1B
Liabilities - DeferredTaxLiabilitiesNoncurrent	$2.4B	$3.2B	$4.0B	$7.5B	$7.2B
Liabilities - PensionAndPostretirementBenefitLiabilitiesNoncurrent	$7.3B	$7.1B	$6.5B	$8.9B	$10.8B
Liabilities - ContingentConsiderationLiabilityNoncurrent	$1.2B	$1.1B	$1.1B	$533.0M	$633.0M
Liabilities - OtherNoncurrentLiabilities	$17.5B	$13.4B	$10.1B	$10.7B	$11.9B
Liabilities - TotalLiabilities	$108.6B	$98.8B	$110.6B	$108.0B	$111.6B
Equity - PreferredStock	$0	$0	$0	$0	$0
Equity - CommonStock	$3.1B	$3.1B	$3.1B	$3.1B	$3.1B
Equity - RetainedEarnings(deficit)	$155.8B	$153.8B	$128.3B	$123.1B	$113.9B
Equity - TreasuryStock	$75.7B	$75.7B	$41.7B	$39.1B	$38.5B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-11.7B	$-12.5B	$-13.0B	$-13.1B	$-15.2B
Equity - TotalLiabilitiesAndStockholdersEquity	$180.1B	$167.6B	$187.4B	$182.0B	$174.9B

Income Statement 21 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-29	2023-12-31	2023-01-01	2022-01-02	2021-01-03
IncomeStatement - Revenues - NetProductSales/Revenues	$88.8B	$85.2B	$80.0B	$78.7B	$82.6B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold	$27.5B	$26.6B	$24.6B	$23.4B	$28.4B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$17.2B	$15.1B	$14.1B	$14.3B	$12.2B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative(andMarketing)	$22.9B	$21.5B	$20.2B	$20.1B	$22.1B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$4.5B	$4.5B	$3.9B	$4.2B	$4.7B
IncomeStatement - CostsAndExpenses - Depreciation(operating)	$7.3B	$7.5B	$7.0B	$7.4B	$7.2B
IncomeStatement - CostsAndExpenses - RestructuringAndImpairmentCharges	$234.0M	$489.0M	$275.0M	$209.0M	$247.0M
IncomeStatement - OtherIncomeExpense - GrossProfit	$61.4B	$58.6B	$55.4B	$55.3B	$54.2B
IncomeStatement - OtherIncomeExpense - InterestIncome	$1.3B	$1.3B	$490.0M	$53.0M	$111.0M
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$-4.7B	$-6.6B	$-810.0M	$-526.0M	$-2.9B
IncomeStatement - OtherIncomeExpense - Income(loss)FromContinuingOperationsBeforeIncomeTaxes	$16.7B	$15.1B	$19.4B	$19.2B	$16.5B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$2.6B	$1.7B	$3.0B	$1.4B	$1.8B
IncomeStatement - IncomeTax - EffectiveTaxRate(continuingOperations)	$0	$0	$0	$0	$0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$14.1B	$35.2B	$17.9B	$20.9B	$14.7B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$14.1B	$35.2B	$17.9B	$20.9B	$14.7B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$6	$14	$7	$8	$6
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$6	$14	$7	$8	$6
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$2.4B	$2.5B	$2.6B	$2.6B	$2.6B
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$2.4B	$2.6B	$2.7B	$2.7B	$2.7B
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$14.9B	$30.4B	$18.0B	$23.1B	$15.4B

Cash Flow Statement 22 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-29	2023-12-31	2023-01-01	2022-01-02	2021-01-03
CashFlow - OperatingActivities - NetIncome	$14.1B	$35.2B	$17.9B	$20.9B	$14.7B
CashFlow - OperatingActivities - DepreciationAndAmortization	$7.3B	$7.5B	$7.0B	$7.4B	$7.2B
CashFlow - OperatingActivities - ShareBasedCompensation	$1.2B	$1.2B	$1.1B	$1.1B	$1.0B
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-2.2B	$-4.2B	$-1.7B	$-2.1B	$-1.1B
CashFlow - OperatingActivities - ProvisionForDoubtfulAccounts	$11.0M	$0	$-17.0M	$-48.0M	$63.0M
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$-556.0M	$10.4B	$-139.0M	$2.2B	$4.7B
CashFlow - OperatingActivities - NetCashFromOperatingActivities(continuingOperations)	$24.3B	$22.8B	$21.2B	$23.4B	$23.5B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e&Intangibles)	$4.4B	$4.5B	$4.0B	$3.7B	$3.3B
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$15.1B	$0	$17.7B	$60.0M	$7.3B
CashFlow - InvestingActivities - OtherInvestingActivities	$174.0M	$-12.0M	$229.0M	$508.0M	$521.0M
CashFlow - InvestingActivities - NetCashFromInvestingActivities(continuingOperations)	$-18.6B	$878.0M	$-12.4B	$-8.7B	$-20.8B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$6.7B	$0	$2.0M	$5.0M	$7.4B
CashFlow - FinancingActivities - RepaymentsOfDebt	$1.5B	$1.6B	$2.1B	$1.8B	$1.1B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$2.4B	$5.1B	$6.0B	$3.5B	$3.2B
CashFlow - FinancingActivities - PaymentOfDividends	$11.8B	$11.8B	$11.7B	$11.0B	$10.5B
CashFlow - FinancingActivities - OtherFinancingActivities	$-38.0M	$-269.0M	$93.0M	$114.0M	$-294.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities(continuingOperations)	$-3.1B	$-15.8B	$-8.9B	$-14.0B	$-6.1B
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-289.0M	$-112.0M	$-312.0M	$-178.0M	$89.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$2.2B	$7.7B	$-360.0M	$502.0M	$-3.3B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$6.7B	$8.6B	$5.2B	$4.8B	$4.6B
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$1.9B	$1.8B	$933.0M	$941.0M	$841.0M

Johnson & Johnson

Balance Sheet 32 Accounts • 5 Years

Income Statement 21 Accounts • 5 Years

Cash Flow Statement 22 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History